Cited by 45Cancer-related cognitive impairment studiesEstrogen and related hormone effectsEndoplasmic Reticulum Stress and Disease

Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis

Open access
Denk, Franziska, Ramer, Leanne M., Erskine, Erin L. K. S., Nassar, Mohammed A., Bogdanov, Yury, Signore, Massimo, Wood, John N., McMahon, Stephen B. +1 more·2015·Acta Neuropathologica Communications

Abstract

BACKGROUND: Tamoxifen (TAM) is an important cancer therapeutic and an experimental tool for effecting genetic recombination using the inducible Cre-Lox technique. Despite its widespread use in the clinic and laboratory, we know little about its effects on the nervous system. This is of significant concern because TAM, via unknown mechanisms, induces cognitive impairment in humans. A hallmark of cellular stress is induction of Activating Transcription Factor 3 (Atf3), and so to determine whether TAM induces cellular stress in the adult nervous system, we generated a knock-in mouse in which Atf3 promoter activity drives transcription of TAM-dependent Cre recombinase (Cre-ERT2); when crossed with tdtomato reporter mice, Atf3 induction results in robust and permanent genetic labeling of cells in which it is up-regulated even transiently. RESULTS: We found that granular neurons of the olfactory bulb and dentate gyrus, vascular cells and ependymal cells throughout the brain, and peripheral sensory neurons expressed tdtomato in response to TAM treatment. We also show that TAM induced Atf3 up-regulation through inhibition of cholesterol epoxide hydrolase (ChEH): reporter expression was mitigated by delivery in vitamin E-rich wheat germ oil (vitamin E depletes ChEH substrates), and was partially mimicked by a ChEH-specific inhibitor. CONCLUSIONS: This work demonstrates that TAM stresses cells of the adult central and peripheral nervous systems and highlights concerns about clinical and experimental use of TAM. We propose TAM administration in vitamin E-rich vehicles such as wheat germ oil as a simple remedy.

AI snapshot

Written from the paper’s full text.

TL;DR

Tamoxifen (TAM) induces cellular stress in the adult mouse nervous system, marked by Atf3-driven reporter recombination in central and peripheral neurons, vasculature, and ependyma. The effect is mediated by inhibition of cholesterol epoxide hydrolase (ChEH), and delivery in vitamin E-rich wheat germ oil reduces TAM-induced Atf3 up-regulation.

Key findings

  • A single 75 mg/kg i.p. TAM dose induced tdtomato reporter expression in granular neurons of the olfactory bulb and dentate gyrus, vascular endothelial and smooth muscle cells, ependymal cells throughout the brain and spinal cord, and dorsal root ganglion (DRG) sensory neurons; more than 20% of DRG neurons were affected after one dose.
  • In DRG, recombination occurred preferentially in large-diameter NF200-positive neurons, with a small percentage in non-peptidergic IB4-positive nociceptors; repeated daily TAM did not increase the proportion of recombined DRG neurons, but ATF3-positive neuronal nuclei were noticeably increased 24 h after a third daily injection.
  • TAM-induced Atf3 up-regulation was linked to ChEH inhibition: TAM in vitamin E-rich wheat germ oil drastically reduced recombination (P < 0.0001, one-way ANOVA), and the selective ChEH ligand DPPE significantly increased recombination in DRG (12.33 ± 2.33 saline vs 26.00 ± 3.21 DPPE, p = 0.026), dentate gyrus (1.17 ± 0.44 vs 8 ± 0.58, p = 0.001), and olfactory bulb (2 ± 0.58 vs 12.33 ± 1.45, p = 0.003).
  • ERα and sigma 1/2 receptor drugs (ICI 182,780, PPT, DTG) did not significantly alter TAM-induced recombination, and recombined neurons did not express the pro-apoptotic marker activated caspase 3.

Methods

  • Generated an ATF3-CreERT2 knock-in mouse in which CreERT2 is driven by the native Atf3 promoter, crossed with a floxed stop ROSA-tdtomato reporter; also used an advillin-CreERT2 reporter line for DRG studies.
  • TAM was given at 75 mg/kg i.p. in sunflower oil, wheat germ oil, or sunflower oil supplemented with vitamin E; additional drugs included ICI 182,780, PPT, DTG, and DPPE, with saline or oil controls.
  • Quantification used confocal imaging of brain sections and DRG whole-mounts, immunohistochemistry for NeuN, calbindin D28k, NF200, CGRP, IB4, TH, and ATF3, recursive translation for DRG cell-size distributions, and statistics including Student’s t-test, one-way ANOVA with Holm-Sidak post-hoc, and Kolmogorov-Smirnov tests.

Limitations

  • The paper states that whether Atf3 induction is due to accumulation of cholesterol epoxides or reduction in cholestane-3β,5α,6β-triol synthesis remains unknown.
  • The paper notes that DPPE cannot induce active nuclear translocation of the ERT2 construct, so DPPE-induced tdtomato expression relies on leaky nuclear translocation and produces far less recombination than TAM; the ATF3-CreERT2 construct also displays TAM-independent leakiness.
  • Evident from the text: vitamin E delivered directly in sunflower oil was less successful at preventing TAM-induced Atf3 expression, likely due to uneven dissolution and increased variability; the study did not directly measure ChEH substrates/products or assess behavioral/cognitive outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40478-015-0255-6

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

19 of 40 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    TAM binds cholesterol epoxide hydrolase (ChEH), an enzyme complex involved in cholesterol biosynthesis.

    “Furthermore, TAM binds other endogenous molecules, including sigma 1 and 2 receptors on the endoplasmic reticulum [10], and cholesterol epoxide hydrolase (ChEH) – an enzyme complex involved in cholesterol biosynthesis [11].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [11] de Medina P, Paillasse MR, Segala G, Poirot M, Silvente-Poirot S. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. Proc Natl Acad Sci U S A. 2010;107:13520–5. doi: 10.1073/pnas.1002922107 . source
  • Premisecitation

    A small number of uninjured sensory neurons express Atf3.

    “We and others have found that a small number of uninjured sensory neurons express Atf3 [23]”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [23] Averill S, Davis DR, Shortland PJ, Priestley JV, Hunt SP. Dynamic pattern of reg-2 expression in rat sensory neurons after peripheral nerve injury. J Neurosci. 2002;22:7493–501. source
  • Premisecitation

    A subpopulation of TAM-treated patients experience cognitive disturbances such as confusion, deterioration of verbal memory, and executive dysfunction (often called "TAM brain fog").

    “TAM, via unknown mechanisms, induces cognitive impairment in humans.”
    • Also stated in: § Introduction · plain
      “there is accumulating evidence that a subpopulation of TAM-treated patients experience cognitive disturbances such as confusion, deterioration of verbal memory, and executive function such as decision-making, symptoms often referred to as “TAM brain fog” [1–4].”
    Quote in the paperSubstantial claim2 of 4 sources checked
    • cites [1] Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer. J Pain Symptom Manage. 2001;21:407–24. doi: 10.1016/S0885-3924(01)00268-8 . source

      The review’s “Mechanisms of Changes in Cognitive Function with Adjuvant Chemotherapy” section (page unavailable) reports tamoxifen-related CNS toxicities, including confusion, and says their mechanism is unclear. It does not specifically attribute verbal-memory deterioration or executive dysfunction to tamoxifen; the cognitive-domain findings in the breast-cancer section concern women receiving chemotherapy, some of whom also received tamoxifen. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [2] Chen X, Li J, Chen J, Li D, Ye R, Zhang J, et al. Decision-making impairments in breast cancer patients treated with tamoxifen. Horm Behav. 2014;66:449–56. doi: 10.1016/j.yhbeh.2014.07.005 . source
    • cites [3] Espeland MA, Shumaker SA, Limacher M, Rapp SR, Bevers TB, Barad DH, et al. Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition. J Womens Health. 2010;19:371–9. doi: 10.1089/jwh.2009.1605 . source

      The Discussion (page not available) reports possible small adverse effects of tamoxifen on global cognition, particularly among older women with lower baseline cognitive scores; it also cites studies suggesting memory effects. But the paper hedges the effect rather than establishing that tamoxifen induces impairment, and it does not identify confusion, executive dysfunction, or “TAM brain fog” as effects in a subpopulation of treated patients. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [4] Palmer JL, Trotter T, Joy AA, Carlson LE. Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv. 2008;2:275–82. doi: 10.1007/s11764-008-0070-1 . source
  • Premisecitation

    Under normal circumstances, Atf3 is expressed in very few regions of the adult nervous system.

    “Under normal circumstances, Atf3 is expressed in very few regions of the adult nervous system [12].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [12] Hunt D, Raivich G, Anderson PN. Activating transcription factor 3 and the nervous system. Front Mol Neurosci. 2012;5:7. doi: 10.3389/fnmol.2012.00007 . source
  • Premisecitation

    TAM's affinity for ChEH is second only to its affinity for ERα.

    “In fact, the affinity of TAM for ChEH is second only to that for ERα, which may underlie its counter-intuitive efficacy in ER-negative breast cancers [11].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [11] de Medina P, Paillasse MR, Segala G, Poirot M, Silvente-Poirot S. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. Proc Natl Acad Sci U S A. 2010;107:13520–5. doi: 10.1073/pnas.1002922107 . source
  • Classified as probably not a substantial claim. 19
  • May combine two claims. 16
  • Classified as probably not a substantial claim.

    Premisecitation

    Atf3 is one of a number of transcription factors upregulated by cellular stress, including the unfolded protein response, tyrosine kinase receptor activation, glutamate receptor hyperactivation, and cellular injury.

    “We generated a knock-in mouse expressing CreERT2 driven by the native promoter for activating transcription factor 3 (Atf3), one of a number of transcription factors upregulated by cellular stress, such as the unfolded protein response, tyrosine kinase receptor activation, glutamate receptor hyperactivation, and cellular injury [12].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [12] Hunt D, Raivich G, Anderson PN. Activating transcription factor 3 and the nervous system. Front Mol Neurosci. 2012;5:7. doi: 10.3389/fnmol.2012.00007 . source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In one study, TAM was associated with loss of glial progenitor cells in the corpus callosum and with reduced cell division in neurogenic regions of the CNS.

    “although in one study it was associated with a loss of glial progenitor cells in the corpus callosum and with reduced cell division in neurogenic regions of the CNS [7].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [7] Chen H-Y, Yang YM, Han R, Noble M. MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. J Neurosci. 2013;33:15069–74. doi: 10.1523/JNEUROSCI.2729-13.2013 . source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    TAM's affinity for ChEH may underlie its counter-intuitive efficacy in ER-negative breast cancers.

    “In fact, the affinity of TAM for ChEH is second only to that for ERα, which may underlie its counter-intuitive efficacy in ER-negative breast cancers [11].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [11] de Medina P, Paillasse MR, Segala G, Poirot M, Silvente-Poirot S. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. Proc Natl Acad Sci U S A. 2010;107:13520–5. doi: 10.1073/pnas.1002922107 . source

      The paper’s opening section says that, after the estrogen receptor, AEBS is tamoxifen’s highest-affinity target; the Discussion links ChEH inhibition to possible anticancer effects. But the paper does not address tamoxifen’s efficacy in ER-negative breast cancers or propose ChEH affinity as an explanation for it. Page numbers are unavailable in our copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    OPC loss was prevented both in vitro and in vivo by MEK1/2 inhibition.

    “OPC loss was prevented both in vitro and in vivo by MEK1/2 inhibition”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [7] Chen H-Y, Yang YM, Han R, Noble M. MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. J Neurosci. 2013;33:15069–74. doi: 10.1523/JNEUROSCI.2729-13.2013 . source
  • May combine two claims.

    Premisecitation

    The Guenthner study used a genetic labeling technique nearly identical to ours, but recombination was driven by promoters for immediate-early genes Fos and Arc, upregulated as part of excitation-transcription neuronal response to synaptic activity initiated by CREB phosphorylation.

    “The Guenthner study [9] used a genetic labeling technique nearly identical to ours, but recombination was driven by promoters for the immediate-early genes Fos and Arc, upregulated as part of the “excitation-transcription” neuronal response to synaptic activity initiated by CREB phosphorylation [40].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [9] Guenthner C, Miyamichi K, Yang H, Heller H, Luo L. Permanent genetic access to transiently active neurons via TRAP: Targeted recombination in active populations. Neuron. 2013;78:773–84. doi: 10.1016/j.neuron.2013.03.025 . source
    • cites [40] Ma H, Groth RD, Wheeler DG, Barrett CF, Tsien RW. Excitation-transcription coupling in sympathetic neurons and the molecular mechanism of its initiation. Neurosci Res. 2011;70:2–8. doi: 10.1016/j.neures.2011.02.004 . source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    MEK1/2 inhibition is one of a number of intracellular messengers that can activate Atf3 expression.

    “one of a number of intracellular messengers that can activate Atf3 expression [12].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [12] Hunt D, Raivich G, Anderson PN. Activating transcription factor 3 and the nervous system. Front Mol Neurosci. 2012;5:7. doi: 10.3389/fnmol.2012.00007 . source

      The ATF3 Induction and Regulation section says several intracellular signaling pathways affect or induce ATF3 expression, supporting the general point. It does not say that MEK1/2 inhibition activates ATF3; its examples instead describe induction through p38 or JNK activation. No page number is available in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    This was accompanied by reduction in their proliferation, and that of neural progenitors in SVZ and dentate gyrus.

    “This was accompanied by a reduction in their proliferation, and that of neural progenitors in the subventricular zone and dentate gyrus”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [7] Chen H-Y, Yang YM, Han R, Noble M. MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. J Neurosci. 2013;33:15069–74. doi: 10.1523/JNEUROSCI.2729-13.2013 . source

      The Results section on systemic tamoxifen treatment reports reduced O-2A/OPC division in vitro and significantly suppressed cell division in the mouse subventricular zone and dentate gyrus. It does not identify the dividing cells in those two regions as neural progenitors; the Discussion says the affected precursor populations remain to be defined. Page numbers are not available in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    TAM has been exploited experimentally to induce permanent reporter expression in newly-born neurons in olfactory bulb and dentate gyrus, in physiologically-active neurons throughout the brain, and in progeny of ependymal cells of intact and injured murine spinal cord.

    “TAM has been exploited experimentally to induce permanent reporter expression in, for example, newly-born neurons in the olfactory bulb and dentate gyrus [8], in physiologically-active neurons throughout the brain [9], and in progeny of ependymal cells of the intact and injured murine spinal cord [39].”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [8] Imayoshi I, Sakamoto M, Ohtsuka T, Takao K, Miyakawa T, Yamaguchi M, et al. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat Neurosci. 2008;11:1153–61. doi: 10.1038/nn.2185 . source
    • cites [9] Guenthner C, Miyamichi K, Yang H, Heller H, Luo L. Permanent genetic access to transiently active neurons via TRAP: Targeted recombination in active populations. Neuron. 2013;78:773–84. doi: 10.1016/j.neuron.2013.03.025 . source
    • cites [39] Barnabé-Heider F, Göritz C, Sabelström H, Takebayashi H, Pfrieger FW, Meletis K, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell. 2010;7:470–82. doi: 10.1016/j.stem.2010.07.014 . source
  • May combine two claims.

    Findingown data

    TAM induces recombination in granular neurons of the dentate gyrus of the hippocampus and olfactory bulb, as well as in vascular and ependymal cells.

    “In the cortex, we found TAM to induce recombination in granular neurons of the dentate gyrus of the hippocampus and olfactory bulb, as well as in vascular and ependymal cells.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    TAM induced Atf3 upregulation in sensory neurons, particularly marked in large proprioceptive NF200 positive cells in trigeminal mesencephalic nucleus and in those projecting to Clarke's column in spinal cord, and to a much lesser extent in non-peptidergic IB4 positive neurons.

    “TAM also induced Atf3 upregulation in sensory neurons, which was particularly marked in large proprioceptive NF200 positive cells in the trigeminal mesencephalic nucleus and in those projecting to Clarke’s column in the spinal cord, and to a much lesser extent in non-peptidergic IB4 positive neurons.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The vast majority of recombined DRG neurons express NF200, with a small percentage also in non-peptidergic IB4 positive nociceptors.

    “The vast majority of recombination occurred in NF200 positive neurons, with a small percentage also in non-peptidergic IB4 positive nociceptors (Fig. 5e).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    In the spinal cord, primary afferent projections of recombined neurons are particularly dense in Clarke's column.

    “In the spinal cord, primary afferent projections to Clarke’s column (a proprioceptive relay to the cerebellum) were particularly dense.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    TAM has the potential to alter neurophysiology via ERα, sigma 1/2 receptors, or ChEH.

    “TAM thus has the potential to alter neurophysiology via any one of these avenues.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: TAM acts at the endogenous estrogen receptor α (ERα).
  • May combine two claims.

    Interpretationown data

    TAM's induction of Atf3 expression occurs via ChEH binding and not via ERα or sigma 1/2 receptors.

    “We also provide evidence that TAM’s induction of Atf3 expression occurs via ChEH binding, and not via ERα or sigma 1/2 receptors.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: TAM acts at the endogenous estrogen receptor α (ERα).
    • Rests on an assumption: DTG is a sigma-1 and -2 receptor agonist.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ICI 182,780 is a pure anti-estrogen.

    “we treated mice with either the anti-estrogen ICI 182,780 (ICI), a “pure” anti-estrogen [17], 4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), a potent ERα agonist [18], or ditolylguanidine (DTG), a sigma-1 and −2 receptor agonist.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [17] Dauvois S, White R, Parker MG. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 1993;106(Pt 4):1377–88. source
  • May combine two claims.

    Premisecitation

    Sunflower oil contains approximately 40 mg/100 g α-tocopherol, while wheat germ oil contains ~150 mg/100 g, nearly four times as much.

    “Sunflower oil (SFO) contains approximately 40 mg/100 g α-tocopherol, while wheat germ oil (WGO) contains ~150 mg/100 g, nearly four times as much [15].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] United States Department of Agriculture. Agricultural Research Service. National Nutrient Database for Standard Reference Release 27. http://ndb.nal.usda.gov/ndb/foods . Accessed 06 October 2015.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    PPT is a potent ERα agonist.

    “we treated mice with either the anti-estrogen ICI 182,780 (ICI), a “pure” anti-estrogen [17], 4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT), a potent ERα agonist [18], or ditolylguanidine (DTG), a sigma-1 and −2 receptor agonist.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [18] Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, eralpha and erbeta, in estrogen target tissues in vivo through the use of an eralpha-selective ligand. Endocrinology. 2002;143:4172–7. doi: 10.1210/en.2002-220403 . source
  • May combine two claims.

    Interpretationreasoning

    Together these data indicate pleiotropic effects of TAM on dentate granule neurons, one involving MEK1/2 activation in immature neural cells (neuronal and glial progenitors), the other reliant upon Atf3 upregulation induced by ChEH inhibition in older adult-born neurons.

    “Together these data indicate pleiotropic effects of TAM on dentate granule neurons, one involving MEK1/2 activation in immature neural cells (neuronal and glial progenitors), the other reliant upon Atf3 upregulation induced by ChEH inhibition in older adult-born neurons.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    The in vitro studies showed that 3 days after cessation of TAM treatment, recombined ependyma could give rise to neurospheres with cells expressing markers for neurons, astrocytes and oligodendrocyte-lineage cells.

    “The in vitro studies showed that 3 days after cessation of TAM treatment, recombined ependyma could indeed give rise to neurospheres with cells expressing markers for neurons, astrocytes and oligodendrocyte-lineage cells.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [39] Barnabé-Heider F, Göritz C, Sabelström H, Takebayashi H, Pfrieger FW, Meletis K, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell. 2010;7:470–82. doi: 10.1016/j.stem.2010.07.014 . source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Mice in treatment and control groups were sex and age-matched.

    “For all experiments, mice in treatment and control groups were sex and age-matched.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    DPPE is a selective ChEH ligand.

    “The selective ChEG ligand N,N-Diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine hydrochloride (DPPE, also known as tesmilifene) was administered at a one-time dose of 50 mg/kg i.p. in saline [21].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [21] Hiramatsu H, Kikuchi Y, Kudoh K, Kita T, Tode T, Nagata I. Growth-inhibitory effects of N, n-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-hcl combined with cisplatin on human ovarian cancer cells inoculated into nude mice. Jpn J Cancer Res. 1997;88:1003–8. source
  • Classified as probably not a substantial claim.

    Premisecitation

    What is absent in anatomical and behavioural experiments assessing role of newly-generated hippocampal neurons in memory formation/retention is a TAM-only control in wild-type mice.

    “What is absent, however, both in anatomical and behavioural experiments assessing the role of newly-generated hippocampal neurons in memory formation/retention, is a TAM-only control in wild-type mice.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [8] Imayoshi I, Sakamoto M, Ohtsuka T, Takao K, Miyakawa T, Yamaguchi M, et al. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat Neurosci. 2008;11:1153–61. doi: 10.1038/nn.2185 . source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Our study does not rule out effects of TAM on neurogenesis.

    “although our study does not rule out effects of TAM on neurogenesis”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    In Barnabé-Heider et al., five daily treatments of TAM (80 mg/kg) were used to induce recombination in ependymal cells in FoxJ1-CreER mice to determine whether ependymal cells are multipotential in vitro, and in vivo following spinal cord injury.

    “Here, five daily treatments of TAM (80 mg/kg) were used to induce recombination in ependymal cells in FoxJ1-CreER mice in order to determine whether ependymal cells are multipotential in vitro, and in vivo following a spinal cord injury.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [39] Barnabé-Heider F, Göritz C, Sabelström H, Takebayashi H, Pfrieger FW, Meletis K, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell. 2010;7:470–82. doi: 10.1016/j.stem.2010.07.014 . source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In vivo, reporter-expressing ependyma self-renewed and produced astrocytes and oligodendrocyte-lineage cells 5 days following last TAM dose.

    “In vivo, reporter-expressing ependyma self-renewed and produced astrocytes and oligodendrocyte-lineage cells 5 days following the last TAM dose.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [39] Barnabé-Heider F, Göritz C, Sabelström H, Takebayashi H, Pfrieger FW, Meletis K, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell. 2010;7:470–82. doi: 10.1016/j.stem.2010.07.014 . source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    In the Imayoshi study, very large doses (400 mg/kg) were administered daily for 4 days, a regimen repeated twice more in some experiments.

    “In the Imayoshi study [8], very large doses (400 mg/kg) were administered daily for 4 days, a regimen that was repeated twice more in some experiments.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [8] Imayoshi I, Sakamoto M, Ohtsuka T, Takao K, Miyakawa T, Yamaguchi M, et al. Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat Neurosci. 2008;11:1153–61. doi: 10.1038/nn.2185 . source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Sunflower oil is relatively low in vitamin E (40 mg/100 g) and wheat germ oil is relatively rich in vitamin E (~150 mg/100 g).

    “Sunflower oil (SFO), which is relatively low in vitamin E (40 mg/100 g), was used as a TAM vehicle and compared with wheat germ oil (WGO), which is relatively rich in vitamin E (~150 mg/100 g) [15].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] United States Department of Agriculture. Agricultural Research Service. National Nutrient Database for Standard Reference Release 27. http://ndb.nal.usda.gov/ndb/foods . Accessed 06 October 2015.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    TAM binding to ChEH inhibits the enzyme's activity, resulting in the accumulation of cholesterol-5,6-epoxides and the inhibition of cholestane-3β,5α,6β-triol production.

    “TAM binding to ChEH inhibits the enzyme’s activity, resulting in the accumulation of cholesterol-5,6-epoxides and the inhibition of cholestane-3β,5α,6β-triol production [26].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [26] Silvente-Poirot S, Poirot M. Cholesterol epoxide hydrolase and cancer. Curr Opin Pharmacol. 2012;12:696–703. doi: 10.1016/j.coph.2012.07.007 . source
    • Rests on an assumption: TAM binds not only mutated ERT2, but also endogenous ERα, ChEH enzyme complex and sigma1/2 receptors.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    The less successful prevention by vitamin E in SFO was likely due to increased variability as a result of difficulties dissolving vitamin E evenly in SFO.

    “This was likely due to increased variability as a result of the difficulties encountered when attempting to dissolve vitamin E evenly in SFO.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: α-tocopherol (vitamin E) prevents the accumulation of cholesterol epoxides.
  • May combine two claims.

    Study design and conductown data

    TAM-induced recombination in the olfactory bulb and dentate gyrus occurs in neurons, as confirmed by colocalization of tdtomato with NeuN and NeuN/calbindin D28k.

    “In the olfactory bulb and dentate gyrus, neuronal expression of reporter was confirmed by colocolization of tdtomato with NeuN (olfactory bulb) and NeuN/calbindin D28k (dentate gyrus) (Fig. 3a, b).”
    Quote in the paperNot a substantial claim
30 of 30
  • The paper relies on this without support.

    TAM is widely used as an experimental tool for manipulating gene expression in vivo via the inducible Cre-Lox technique.

    “Tamoxifen (TAM) is an important cancer therapeutic and an experimental tool for effecting genetic recombination using the inducible Cre-Lox technique.”
    “TAM is a widely-used tool for manipulating gene expression in vivo via the inducible Cre-Lox technique.”
  • The paper relies on this without support.

    TAM acts at the endogenous estrogen receptor α (ERα).

    “What remains little-acknowledged in studies using the Cre-ERT2 system is that TAM acts at the endogenous estrogen receptor α (ERα), hence its clinical use in cancer.”
  • The paper relies on this without support.

    Vitamin E depletes ChEH substrates.

    “reporter expression was mitigated by delivery in vitamin E-rich wheat germ oil (vitamin E depletes ChEH substrates)”
  • The paper relies on this without support.

    DTG is a sigma-1 and -2 receptor agonist.

    “or ditolylguanidine (DTG), a sigma-1 and −2 receptor agonist.”
  • The paper relies on this without support.

    TAM binds not only mutated ERT2, but also endogenous ERα, ChEH enzyme complex and sigma1/2 receptors.

    “TAM binds not only the mutated estrogen receptor (ERT2), but also endogenous ERα, the ChEH enzyme complex and the sigma1/2 receptors.”
  • The paper relies on this without support.

    α-tocopherol (vitamin E) prevents the accumulation of cholesterol epoxides.

    “we took advantage of the fact that α-tocopherol (vitamin E) prevents the accumulation of cholesterol epoxides.”
  • The paper relies on this without support.

    DPPE cannot induce active nuclear translocation of the ERT2 construct and tdtomato induction is therefore entirely reliant on leaky nuclear translocation of CreERT2.

    “This was expected, since DPPE cannot induce active nuclear translocation of the ERT2 construct and tdtomato induction is therefore entirely reliant on leaky nuclear translocation of CreERT2.”
  • The paper relies on this without support.

    This is the first study to directly assess the effects of TAM on cellular stress-induced Atf3 expression in the nervous system.

    “This is the first study to directly assess the effects of TAM on cellular stress-induced Atf3 expression in the nervous system.”
  • The paper relies on this without support.

    Patients prescribed tamoxifen take the medication on a daily basis.

    “patients prescribed tamoxifen take the medication on a daily basis.”
  • The paper relies on this without support.

    In all three above studies, TAM was delivered in corn oil, which has a vitamin E content of ~14.3 mg/100 g, compared to ~40 mg/100 g in SFO and ~150 mg/100 g in WGO.

    “In all three of the above studies, TAM was delivered in corn oil, which has a vitamin E content of ~14.3 mg/100 g, compared to ~40 mg/100 g in SFO and ~150 mg/100 g in WGO.”
10 of 10

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tamoxifen is known to be toxic to humans and rodents at high doses.

    “Tamoxifen is known to be toxic to humans and rodents at high doses [72–74]; therefore, it is possible that giving tamoxifen at 300 mg/kg, compared to 1 mg/kg [39, 55], was toxic and induced neuronal cell death.”

    From Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury (2020) · cites this paper as [72]

    The Results report that 75 mg/kg tamoxifen repeatedly stressed otherwise healthy mouse neurons, and the Introduction reports cognitive disturbances in some treated patients. But the paper does not establish toxicity in humans specifically at high doses; its Discussion says the consequences of a very-high-dose mouse regimen remain unknown. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • DPPE is described as both inhibiting and activating ChEH

    Minor

    The abstract calls DPPE a ChEH-specific inhibitor, but the discussion says it directly activates ChEH. This reverses the proposed mechanism used to interpret its effect on Atf3.

1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Denk, F., Ramer, L. M., Erskine, E. L. K. S., Nassar, M. A., Bogdanov, Y., Signore, M., Wood, J. N., McMahon, S. B., & Ramer, M. S.
Affiliations
  • King's College London (GB)
  • University of British Columbia (CA)
  • University of Sheffield (GB)
  • University College London (GB)
Corresponding author
Ramer, Matt S.
Venue
Acta Neuropathologica Communications
Published
2015-11-26
Volume
3
Issue
1
Pages
74-74
ISSN
2051-5960 (ISSN-L)
OpenAlex
W2177532767
Cited by
44
References
40
Citations by year
2026: 3 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6
FWCI
2.15
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Wellcome Trust (PNWRAQR)
  • Natural Sciences and Engineering Research Council of Canada (RGPIN 250355-1)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Keywords
tamoxifen, cellular stress, ATF3, cholesterol synthesis inhibition, dentate gyrus, ependymal cells, vascular cells, sensory neurons, Cre-loxP recombination, CreERT2, tdTomato reporter, wheat germ oil, vitamin E, cognitive impairment, neurotoxicity
MeSH terms
Animals, Cholesterol, Dose-Response Relationship, Drug, Epoxide Hydrolases, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Nerve Tissue Proteins, Nervous System, Neurons, Plant Oils, Promoter Regions, Genetic, Tamoxifen, Vitamin E, Calcitonin Gene-Related Peptide, Up-Regulation, Selective Estrogen Receptor Modulators, Plant Lectins, Mice, Activating Transcription Factor 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review